Why 4DMedical, Core Lithium, Fenix, and Goodman shares are storming higher today

The S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and is pushing higher. In afternoon trade, the benchmark index is up 0.6% to 8,754.7 points.

Four ASX shares that are rising more than most today are listed below. Here’s why they are storming higher:

4DMedical Ltd (ASX: 4DX)

The 4DMedical share price is up 6% to $3.79. This respiratory imaging technology company’s shares have been on fire again this month. The driver of this has been a commercial arrangement for the clinical use of its CT:VQ platform with United States-based Cleveland Clinic. CT:VQ is a CAT scan-based ventilation-perfusion software. 4DMedical’s founder and CEO, Andreas Fouras, said: “In just over three months since FDA clearance, we’ve established CT:VQ at three of America’s leading academic medical centres: Stanford, University of Miami, and Cleveland Clinic. This rapid adoption by elite institutions demonstrates the compelling clinical and operational advantages of CT:VQ over traditional nuclear VQ imaging.”

Core Lithium Ltd (ASX: CXO)

The Core Lithium share price is up 2.5% to 27.7 cents. This morning, this lithium miner announced the sale of non-core uranium assets. It has sold its 100% interests in the Napperby, Fitton, and Entia Uranium Projects for a cash consideration of $2.5 million to Elevate Uranium Ltd (ASX: EL8). The deal also includes $2.5 million in Elevate Uranium shares and a net smelter royalty of 1% on any metals or minerals produced from the Napperby project area. Core Lithium’s CEO, Paul Brown, said: “We’re pleased to enter into this transaction for our non-core uranium assets which sharpens our strategic focus as a lithium developer and advances our Finniss operation towards a restart.”

Fenix Resources Ltd (ASX: FEX)

The Fenix Resources share price is up 5.5% to 47.5 cents. This follows the release of the results of a scoping study into the opportunity to expand production, reduce costs, and extend mine life from the Weld Range Iron Ore Project. The study found that Fenix could lift production from the Weld Range from 6Mtpa in 2028 to 10Mtpa by 2031, with operations continuing through to 2042. It also believes it can reduce life of mine C1 cash costs to ~A$55.40 per wet metric tonne. This is 27% lower than the midpoint of its FY 2026 guidance range.

Goodman Group (ASX: GMG)

The Goodman Group share price is up almost 9% to $31.77. This has been driven by news that the industrial property giant has signed an agreement with the Canada Pension Plan Investment Board to establish a A$14 billion European data centre partnership. The partnership’s portfolio will comprise four projects totalling 435 MW of primary power and 282 MW of IT load. This includes two centres in Paris (PAR01 and PAR02), one in Frankfurt (FRA02), and one in Amsterdam (AMS01).

The post Why 4DMedical, Core Lithium, Fenix, and Goodman shares are storming higher today appeared first on The Motley Fool Australia.

More reading

• My 5 top stocks to buy in 2026
• Goodman shares rocket 8% on $14b European data centre news
• Goodman Group announces $14bn European data centre partnership with CPP Investments
• Is it too late to buy surging ASX lithium shares like Mineral Resources and Liontown?
• Could these ASX ETFs be set for a rebound in 2026?

Motley Fool contributor James Mickleboro has positions in Goodman Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.